A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia

NCT05345938 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Adjust the research strategy.

Conditions

Relapsed or Refractory Acute Myeloid Leukemia (AML)

Interventions

DRUG: Mitoxantrone Hydrochloride Liposome

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.